Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qlarity is a natural health product (NHP) developed by Dr. Lakshmi P. Kotra's research group at the University of Toronto and the University Health Network (UHN). Authorized by Health Canada under Natural Product Number (NPN) 80144141, the product is a standardized botanical extract derived from green coffee beans (*Coffea canephora*). It is specifically formulated to contain a defined ratio of caffeine and chlorogenic acids (primarily 5-O-caffeoylquinic acid). Qlarity is marketed to support metabolic health and enhance mental alertness by leveraging the synergistic effects of its primary phytochemical constituents. The formulation aims to provide cognitive and metabolic benefits while minimizing the jitteriness often associated with high-dose caffeine consumption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qlarity.